Data analytics company focused on credit scoring services.
AI-generated insights about FICO from various financial sources
Criticized for egregious monopolistic behavior and extreme price hikes.
Short position due to existential threat from VantageScore and excessive pricing disadvantage in mortgage scoring.
Loss of monopoly status in mortgage scoring as FHFA approves competitors; Steve Eisman maintains a short position.
Caution advised due to aggressive pricing strategies creating hostility with banks and government.
Currently experiencing a 50% sell-off due to political scrutiny and antitrust investigations despite an 88% operating margin and monopolistic position.
A short thesis was presented based on regulatory risk from the FHFA and technological disruption from lenders and BNPL firms developing their own proprietary, near real-time credit models, which threaten FICO's backward-looking scoring system.
Despite being down 11% in 2025, the long-term outlook is bullish due to its powerful moat, as the FICO score is deeply embedded in the US credit system, giving it durable pricing power.
Chuck Acrie's firm bought a sizable position during a recent sell-off, which the host viewed as a 'great trade', suggesting the stock was a value opportunity.
The company's guidance for future earnings was weak. It has initiated a price war, which is viewed as a 'very risky business strategy' because its competitors are also its essential data suppliers, threatening its business model.
The stock dropped an unusual 9.5%, which was highlighted as a 'significant red flag' for consumer health.
Criticized for egregious monopolistic behavior and extreme price hikes.
Short position due to existential threat from VantageScore and excessive pricing disadvantage in mortgage scoring.
Loss of monopoly status in mortgage scoring as FHFA approves competitors; Steve Eisman maintains a short position.
Caution advised due to aggressive pricing strategies creating hostility with banks and government.
Currently experiencing a 50% sell-off due to political scrutiny and antitrust investigations despite an 88% operating margin and monopolistic position.
A short thesis was presented based on regulatory risk from the FHFA and technological disruption from lenders and BNPL firms developing their own proprietary, near real-time credit models, which threaten FICO's backward-looking scoring system.
Despite being down 11% in 2025, the long-term outlook is bullish due to its powerful moat, as the FICO score is deeply embedded in the US credit system, giving it durable pricing power.
Chuck Acrie's firm bought a sizable position during a recent sell-off, which the host viewed as a 'great trade', suggesting the stock was a value opportunity.
The company's guidance for future earnings was weak. It has initiated a price war, which is viewed as a 'very risky business strategy' because its competitors are also its essential data suppliers, threatening its business model.
The stock dropped an unusual 9.5%, which was highlighted as a 'significant red flag' for consumer health.